aTyr Pharma (NASDAQ:LIFE) reported quarterly losses of $(0.46) per share which met the analyst consensus estimate. This is a 9.52 percent decrease over losses of $(0.42) per share from the same period last year.
Akerna Releases 2021 Cannabis Report Highlighting Growth In Industry
It’s no secret that cannabis is a growing industry.